Taienkang Pharmaceutical Group has three major R&D bases, gathering nearly 200 R&D elites, of which the proportion of Ph.D. and master's degree talents reaches 20%. The R&D team is strong and experienced, and is good at process optimization, reduce costs and respond quickly to market changes, so as to ensure the company's competitive advantages.

In addition, the company has a professional quality management team and state-of-the-art equipment and instruments, and is committed to providing customers with quality research and stability study services for APIs and intermediates that meet domestic and international registration requirements. From the development, optimization, validation and transfer of analytical methods to the study of quality standards, to stability studies and product release tests, the company is able to provide a full range of solutions.

The quality management system strictly follows the international cGMP standards of China, Europe, America and Japan to ensure that each batch of products reaches the highest quality. The company's regulatory affairs team has rich experience in domestic and overseas registrations, and is able to provide customers with efficient and professional services.

We firmly believe that Sichuan Taienkang will win more customers' trust and support with excellent quality and professional service, and to be a leader in the pharmaceutical field.